Omeros (OMER) Operating Expenses (2010 - 2026)
Omeros (OMER) posted Operating Expenses of $27.3 million for Q1 2026, down 6.08% sequentially from $29.1 million in Q4 2025, and down 21.89% YoY from $35.0 million in Q1 2025.
Omeros (OMER) Operating Expenses (2010 - 2026) Analysis & Trends
Omeros has reported Operating Expenses for 17 years, with the latest figure at $27.3 million in Q1 2026.
- Quarterly Operating Expenses fell 21.89% year-over-year to $27.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $115.1 million (down 29.31% YoY) and the FY2025 annual result came in at $122.8 million, down 26.45% from the prior year.
- Operating Expenses retreated to $27.3 million in Q1 2026 per OMER's latest filing, from $29.1 million in the prior quarter.
- Over five years, Operating Expenses peaked at $59.2 million in Q2 2024 and troughed at $26.4 million in Q3 2025.
- A 5-year average of $37.9 million and a median of $35.7 million in 2023 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2024 and 2025: Operating Expenses jumped 44.64% in 2024, then sank 45.31% in 2025.
- Over 5 years, Operating Expenses stood at $40.1 million in 2022, then declined by 0.93% to $39.8 million in 2023, then retreated by 16.12% to $33.4 million in 2024, then retreated by 12.81% to $29.1 million in 2025, then decreased by 6.08% to $27.3 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $27.3 million, $29.1 million, and $26.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Omeros | 1.24 Bn | 1.24 Bn | 27.73 Mn | 28.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28.46 Mn |
| Mar 31, 2026 | 27.31 Mn |
| Dec 31, 2025 | 29.08 Mn |
| Sep 30, 2025 | 26.39 Mn |
| Jun 30, 2025 | 32.35 Mn |
| Mar 31, 2025 | 34.97 Mn |
| Dec 31, 2024 | 33.36 Mn |
| Sep 30, 2024 | 35.41 Mn |
| Jun 30, 2024 | 59.16 Mn |
| Mar 31, 2024 | 39.03 Mn |
| Dec 31, 2023 | 39.77 Mn |
| Sep 30, 2023 | 48.15 Mn |
| Jun 30, 2023 | 40.90 Mn |
| Mar 31, 2023 | 35.71 Mn |
| Dec 31, 2022 | 40.14 Mn |
| Sep 30, 2022 | 50.77 Mn |
| Jun 30, 2022 | 37.44 Mn |
| Mar 31, 2022 | 35.05 Mn |
| Dec 31, 2021 | 42.89 Mn |
| Sep 30, 2021 | 39.83 Mn |